Physicians across 25 Asian countries report that tuberculosis (TB) frequently mimics childhood cancer, leading to delayed diagnoses and disrupted oncologic care.
According to research published in Cureus, clinicians often initiate empirical antitubercular therapy before confirming a malignancy, a practice that complicates treatment intensity and increases the risk of adverse drug-drug interactions.
The diagnostic intersection of TB and pediatric malignancy remains a persistent challenge in regions where both diseases are endemic. Because both conditions present with systemic symptoms—such as persistent fever, weight loss, and lymphadenopathy (swollen lymph nodes)—physicians often struggle to differentiate between them without definitive histological or microbiological evidence. Cureus reported that, of the 41 pediatric oncologists surveyed, 90.2% identified Hodgkin lymphoma as the malignancy most frequently misdiagnosed as tuberculosis.
This diagnostic delay is not merely a clinical inconvenience; it has tangible consequences for patient outcomes. When empirical antitubercular therapy (ATT) is started prematurely, the window for timely initiation of chemotherapy closes, potentially allowing the cancer to advance.
The study highlights that 65.8% of respondents reported treatment interruptions due to interactions between antitubercular drugs and chemotherapeutic agents, while 44% of centers found it necessary to modify the intensity of cancer treatments to accommodate concurrent TB management.
| Clinical Complication | Reported Frequency (n=41) |
|---|---|
| Hodgkin lymphoma misdiagnosed as TB | 90.2% (n=37) |
| Treatment interruptions from drug interactions | 65.8% (n=27) |
| Modification of cancer therapy intensity | 44.0% (n=18) |
| Empirical TB treatment prior to cancer diagnosis | 14.6% (n=6) |
The data shows a systemic gap in standardized screening protocols across Asian healthcare institutions. While screening is often performed selectively before high-stakes procedures like hematopoietic stem cell transplantation, routine screening for TB upon a cancer diagnosis is not standard practice. The heterogeneity in diagnostic resources across the 25 participating countries further complicates the development of a unified management strategy.
“The clinical intersection of TB and childhood cancer in endemic regions creates significant management challenges, as both diseases present similarly with non-specific symptoms.”
noted the study authors in their assessment of current regional practices. The reliance on empirical therapy—treating a patient for a suspected condition before confirmed results are available—remains a major point of friction in oncologic care.
Clinicians must be particularly cautious with the administration of hepatotoxic drugs, as both chemotherapy and certain antitubercular regimens can place significant stress on liver function. Patients undergoing concurrent therapy require careful monitoring of blood counts and metabolic markers to mitigate the risks of synergistic toxicity, where the combined effect of two or more drugs is greater than the sum of their individual effects.
The study, which received ethics approval for its anonymous, web-based methodology, highlights the urgent need for prospective studies. Standardized diagnostic algorithms could help oncologists differentiate between TB and malignancy earlier, preventing unnecessary delays in life-saving cancer treatment.
Cureus began in 2009 under the name PeerEMed before adopting its current title in 2012. The journal is known for a unique publication model that combines pre-publication peer review with an optional post-publication system, which utilizes a trademarked Scholarly Impact Quotient to weight expert opinions. This approach is designed to facilitate an unusually fast review process compared to standard medical journals.
In 2022, the journal became part of the Springer Nature group. While it is indexed in databases such as PubMed Central and Google Scholar, its editorial practices have faced scrutiny. The journal previously maintained a feature to highlight authors who committed ethical violations and has undergone several instances of large-scale retractions, including the removal of 56 papers in 2024.
Always seek the advice of a qualified healthcare provider with any questions regarding a medical condition.
Worth a look
- Northeastern London Wins £327,500 Grant to Model Pandemic Behavior
- Baltimore Health Officials Investigate Legionnaires’ Cases at Residence Inn Near Johns Hopkins
- Eating Yogurt Twice Weekly Linked to Lower Risk of Aggressive Right-Side Colon Cancer (archynewsy.com)
- Pope Leo XIV Cleared for South America Tour After Lung Cancer Surgery (newsdirectory3.com)